Abstract
This study aimed at identifying the factors associated with neonatal mortality. We analyzed the Demographic and Health Survey (DHS) datasets from 10 Sub-Saharan countries. For each survey, we trained machine learning models to identify women who had experienced a neonatal death within the 5 years prior to the survey being administered. We then inspected the models by visualizing the features that were important for each model, and how, on average, changing the values of the features affected the risk of neonatal mortality. We confirmed the known positive correlation between birth frequency and neonatal mortality and identified an unexpected negative correlation between household size and neonatal mortality. We further established that mothers living in smaller households have a higher risk of neonatal mortality compared to mothers living in larger households; and that factors such as the age and gender of the head of the household may influence the association between household size and neonatal mortality.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Bill & Melinda Gates Foundation, investment ID 52720.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The protocols, procedures, and questionnaires used to conduct the Demographic and Health Surveys analyzed in this study were reviewed and approved by ICF International's Institutional Review Board (IRB) and host country IRBs for country-specific protocols. The ICF IRB ensures that the survey complies with the U.S. Department of Health and Human Services regulations for the protection of human subjects (45 CFR 46). Host country IRBs ensure that country-specific surveys comply with local laws and norms. The DHS program sought informed consent from all respondents of the DHS surveys before each interview. The informed consent statements provide details regarding the study and emphasized that each respondent's participation was voluntary, the respondent may refuse to answer any question, and the respondent may terminate participation at any time. All respondents's identities and information were kept strictly confidential and all the data were de-identified before being made publicly available.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
This study analyzed the publicly available Demographic and Health Survey (DHS) Data. We applied for and received explicit approval from ICF to access and analyze DHS data from the 10 countries studied: Burkina Faso, Congo Democratic Republic, Ethiopia, Ghana, Kenya, Nigeria, Senegal, South Africa, Tanzania, and Zambia. The approval was received through a letter from the DHS Program's Data Archivist addressed to William Ogallo (william.ogallo{at}ibm.com)
